Home Serum albumin-bound proteomic signature for early detection and staging of hepatocarcinoma: sample variability and data classification
Article
Licensed
Unlicensed Requires Authentication

Serum albumin-bound proteomic signature for early detection and staging of hepatocarcinoma: sample variability and data classification

  • Carlo M. Camaggi , Elena Zavatto , Laura Gramantieri , Valeria Camaggi , Elena Strocchi , Roberto Righini , Luca Merina , Pasquale Chieco and Luigi Bolondi
Published/Copyright: May 31, 2010

Abstract

Background: Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) proteomic signature might be of interest for the early detection and staging of hepatocellular carcinoma (HCC). However, published procedures have been criticized for the lack of data about analytical reproducibility, and the use of inadequate data processing.

Methods: MALDI-TOF profiling of peptides bound to serum albumin (“albuminome”) was performed using 90 μL of serum from 45 study subjects (HCV-related cirrhosis, small, unifocal HCCs and advanced HCCs). To overcome the large intra-sample variability, a Quality Assurance protocol was implemented, and 4–8 samples for each subject were processed and analyzed. Overall, 522 subject samples and 299 quality-control spectra were analyzed. A machine-learning approach (Random Forest) was applied to analyze the data sets.

Results: Mean intra-sample coefficient of variation (CV) of the analytical procedure was 17.6%–30.0%; inter-subject CV was in the range 48.8%–71.3% among the three study groups. The Random Forest procedure correctly classified 433/522 “patient samples” and 295/299 “reference samples”; 43/45 patients were correctly classified following this approach.

Conclusions: Our data suggest that, notwithstanding the large analytical variability found, multiple proteomic profiles obtained from each subject can differentiate cirrhosis with and without HCC, and HCCs with and without vascular invasion, warranting further investigation in a prospective setting.

Clin Chem Lab Med 2010;48:1319–26.


Corresponding author: Luigi Bolondi, MD, Divisione di Medicina Interna – Università degli Studi di Bologna, via Albertoni, 15. 40138 Bologna, Italy Phone: +39 051 6362260, Fax: +39 051 6362725,

Received: 2009-11-17
Accepted: 2010-3-21
Published Online: 2010-05-31
Published in Print: 2010-09-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. Lost in translation…wallowing in transformation?
  3. Reviews
  4. Coeliac disease – a diagnostic and therapeutic challenge
  5. Advancements in anemias related to chronic conditions
  6. Opinion Paper
  7. Translations of the “Evidence-Based Medicine” concept in different languages: is it time for international standardisation?
  8. Genetics and Molecular Diagnostics
  9. Rapid detection of glycogen storage disease type Ia by DNA microarray
  10. Transfer of myxovirus-protein-A mRNA assay for interferon-β bioactivity measurement in multiple sclerosis patients to routine laboratory practice. A 4-year experience
  11. General Clinical Chemistry and Laboratory Medicine
  12. Transferrin receptor expression on reticulocytes as a marker of iron status in dialyzed patients
  13. Quartz crystal microbalance-based biosensor for the detection of α-thalassemia 1 (SEA deletion)
  14. Retrospective analysis of 88,429 serum and urine glucose EQA results obtained from professional laboratories and medical offices participating in surveys organized by three European EQA centers between 1996 and 2007
  15. Liquid phase immunoassays utilizing magnetic markers and SQUID magnetometer
  16. L-Phenylalanine concentration in blood of phenylketonuria patients: a modified enzyme colorimetric assay compared with amino acid analysis, tandem mass spectrometry, and HPLC methods
  17. Amniotic fluid α-fetoprotein microheterogeneity in the prenatal diagnosis of congenital disorders of glycosylation type Ia
  18. Minor histocompatibility antigen HA-1 and HA-2 polymorphisms in Taiwan: frequency and application in hematopoietic stem cell transplantation
  19. Reference Values and Biological Variations
  20. Blood cell and iron status analytes of preterm and full-term infants from 20 weeks onwards during the first year of life
  21. Cancer Diagnostics
  22. Quantitative denaturing high performance liquid chromatography (Q-dHPLC) detection of APC long DNA in faeces from patients with colorectal cancer
  23. Rapid intraoperative parathyroid hormone assay in fine needle aspiration for differential diagnosis in thyroid and parathyroid surgery
  24. Serum albumin-bound proteomic signature for early detection and staging of hepatocarcinoma: sample variability and data classification
  25. Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test
  26. Cardiovascular Diseses
  27. Diagnostic accuracy of B-type natriuretic hormone for congenital heart disease in the first month of life
  28. Carcinoembryonic antigen concentrations in patients with acute coronary syndrome
  29. Evolution of vitamin D binding protein concentration in sera from cardiac surgery patients is determined by triglyceridemia
  30. Letters to the Editor
  31. Effect of storage temperature or collection tube type on blood methylmalonic acid concentrations measured by gas chromatography-mass spectrometry
  32. Acute porphyrias may be overlooked in patients taking methenamine hippurate
  33. Reduced plasma apolipoprotein A-V concentrations in two lecithin:cholesterol acyltransferase deficient patients
  34. Salivary calcium: a risk indicator in periodontal disease
  35. S100B protein increases in human blood and urine during stressful activity
  36. Congress Abstracts
  37. Congress of Clinical Chemistry and Laboratory Medicine 7th Annual Conference of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL) Mannheim, Germany, 29th September – 02nd October, 2010
  38. 9th National Congress of the Greek Society of Clinical Chemistry Athens, Greece, October 7 – 9, 2010
  39. 42nd National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology ROME MARRIOTT PARK HOTEL, Rome (Italy), 5 – 8 October 2010
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.248/pdf
Scroll to top button